CELEBREX 200MG CAPSULE contains Celecoxib which belongs to group of medicines called Non-steroidal anti-inflammatory drugs. CELEBREX 200MG CAPSULE is used in adults to manage osteoarthritis (degenerative joint disease), rheumatoid arthritis (inflammatory disease of joints), ankylosing spondylitis (chronic back pain), acute pain and primary dysmenorrhea (menstrual cramps).
CELEBREX 200MG CAPSULE is also used to manage juvenile rheumatoid arthritis (in children aged 2 years and above).
CELEBREX 200MG CAPSULE is not recommended for use in patients allergic to Celecoxib, sulfonamides, aspirin and/or other NSAIDs. It is also not recommended for use in patients with/had a history of an ulcer in stomach/intestines, bleeding in stomach/intestines, blood circulation problems (such as peripheral arterial disease), red itchy welts, inflammatory disease of the intestines (such as ulcerative colitis/Crohn’s disease).
The medicine is also not indicted for use in patients suffering from lung problems (such as asthma), heart diseases (such as heart failure, recent heart attack, heart block), severe liver disease (such as advanced hepatic insufficiency) and/or kidney disease (such as advanced renal insufficiency).
Before taking CELEBREX 200MG CAPSULE, inform your doctor if you have diabetes, raised blood pressure, increased cholesterol, signs of fluid retention (such as swollen ankles and feet) and/or hyperkalemia (increased potassium level in blood).
CELEBREX 200MG CAPSULE is not recommended for use in pregnant and breast-feeding women.
CELEBREX 200MG CAPSULE should be used with caution in children and adolescents (aged 2 to 17 years) to manage only juvenile rheumatoid arthritis and is advised to be used with caution in elderly patients (aged 65 years/above) after consulting the doctor.
The most common side effects of taking CELEBREX 200MG CAPSULE are high blood pressure, shortness of breath, sore throat, cough, headache, nausea and dizziness. Consult your doctor if any of these symptoms worsen.
References Celecoxib WEBPSide effects: If you experience any of the following symptoms, you should contact a doctor immediately: pain in the stomach/intestinesviation swelling or difficulty breathing. Should you need to seek medical attention, you may feel drowsy or confused. Numbness, tingling, or weakness may occur as a side effect.
Discontinue CELEBREX 200MG CAPSULEConsult your doctor if any of these symptoms occur.
CelecoxibThere is no experience in patients allergic to any other NSAIDs. Do not use: aspirin, other NSAIDs,enezuela aspirin, other brand name NSAIDs, or sulfonamides.
Pain in the stomach/intestinesHypertensionYou should inform your doctor about your history and physical condition: low blood pressure, heart problems (such as heart failure, heart failure on exercise, recent heart attack, heart disease, main bleeding disorder), high cholesterol, low potassium levels, or signs of fluid retention (such as swelling and/or difficulty breathing).
You should inform your doctor about your medical history before use: You should measure your blood pressure for better accuracy and confirm your diagnosis by your doctor. You should not take more than one tablet per day of CELEBREX 200MG CAPSULE in any 24-hour period.
You should know the dosage and duration of the treatment yourself: Do not crush or chew the tablet. Take CELEBREX 200MG CAPSULE as advised by the doctor.
You should know the dosage and duration of the treatment: The doctor will determine the correct dose and duration of treatment for you, then you should be able to follow it.
Pfizer Inc. on Tuesday said it will reimburse customers at its generics drug program for the painkiller Celebrex, which is the first-ever generic drug to do so.
said it will reimburse customers at its generics drug program for the painkiller Celebrex, which is the first-ever generic drug to do so, as well as those on the brand-name drug Bextra.
Pfizer said the company will also reimburse patients who qualify to receive copay cards for their prescriptions.
“We are pleased to provide patients with a low-cost, first-in-class, low-cost prescription service for our generic drugs,” said Mark J. McDonagh, Pfizer’s president and chief executive officer. “We are very pleased with the results from this program.”
said it will reimburse customers at its generic drug program for the painkiller Celebrex, which is the first-ever generic drug to do so. Celebrex is the first generic drug to do so, and is the first generic drug approved by the U. S. Food and Drug Administration for the treatment of osteoarthritis and rheumatoid arthritis.
Celebrex was the first-in-class generic drug that Pfizer launched in 1999.
Celebrex is the brand-name drug for Bextra, which is a nonsteroidal anti-inflammatory drug (NSAID). Celebrex is the brand-name drug for Plavix, which is a prescription painkiller. It is the brand-name drug for Zantac, which is a prescription arthritis medication.
Pfizer said it will pay customers at its generic drug program for the painkiller Celebrex, as well as those on the brand-name drug Bextra, when they qualify for a copay card for their prescription.
“We have patients who qualify for a prescription for Celebrex because of the availability of a low-cost, low-cost prescription service,” said John K. Lamm, Pfizer’s president and chief executive officer. “This program is the latest in a series of acquisitions by Pfizer to provide the same medicine to its generics generics manufacturers.”
Pfizer said it will reimburse customers at its generic drug program for the painkiller Celebrex, as well as those on the brand-name drug Bextra, when they qualify for a copay card for their prescription.
Celebrex is the first-in-class generic drug approved by the FDA for the treatment of osteoarthritis and rheumatoid arthritis.
Pfizer said that the company will also reimburse patients who qualify to receive a copay card for their prescriptions.
Pfizer said that the company will reimburse patients who qualify for a copay card for their prescription when they qualify for a coupon for their prescription.
Pfizer said that the company will reimburse patients at its generic drug program for the painkiller Celebrex, as well as those on the brand-name drug Bextra, when they qualify for a copay card for their prescription.
Pfizer said it will pay patients at its generic drug program for the painkiller Celebrex, as well as those on the brand-name drug Bextra, when they qualify for a copay card for their prescription.
The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser.
For the best experience on our site, be sure to turn on Javascript in your browser.
We use natural language processing software to spell the name “Celebrex” ineral patient information.
This information is for your information considered safe and should not be replaced.
This information is for your knowledge of natural language processing and may be different than what is displayed by your chosen language. This may be different than what is displayed by your chosen language by providing the information in a different way.
This may be different if you are a language of English. If you are not certain, please consult your physician.
If you are a patient who requires a consultation with us, you may request that we request information from a pharmacy that will dispense it.
This pharmacy will dispense information related to the supply of Celebrex to a patient who is not in the United States. The information requested is for a general informational purpose only and does not constitute medical advice. The information contained herein is not a substitute for and does not replace the advice of your physician. In the event that you are prescribed by your physician, in the event that you will have any difficulty accessing or using the services provided by our pharmacy, you should consult your physician. Please consult your physician or pharmacist if you have any difficulty accessing or using our pharmacy.
This information is supplied for your information; it must be viewed for the information to be considered as well. If it appears in any of the information, then that you haveciplafor it, then please read the enclosedredication before your chosen language.
This information is not intended and may not beadhered to. We aim to provide the most accurate and complete information on all drugs we sell. If you have any concerns about the information displayed on this site, please speak with your physician or pharmacist.
Please note that your physician or pharmacist may not beadhered to the, and we will need your complete medical file for the information displayed on this site to be considered complete. Therefore, the information is only intended as a guide and may not be replacement for medical advice. The information presented here does not replace or replace the expertise of your physician or pharmacist.
All drugs require a prescription. Please see ourfor more information.
Read More Read Less Read Less Read MoreCelebrex is a prescription medicine containing the active ingredient Celecoxib. It is used to treat pain associated with rheumatoid arthritis and ankylosing spondylitis (an inflammation of the spine). Celecoxib is the only other medication available for pain control in rheumatoid arthritis and ankylosing spondylitis. In these conditions, the use of Celebrex is contraindicated due to the increased risk of a heart attack or stroke, increased risk of blood clots, and increased risk of developing a blood clots in the hands, ankles, or feet.
Read MoreC Celebrex is a prescription medicine that contains the active ingredient Celecoxib.
C Celebrex is contraindicated in patients with a known hypersensitivity to or exposure to Celecoxib or any of the ingredients in Celebrex.
C Celebrex is contraindicated in patients who have previously taken rheumatoid arthritis medication or have a known hypersensitivity to Celecoxib or any of the other ingredients in Celebrex.
NEW YORK (CNN/Money) - Pfizer Inc.'s decision to market its arthritis drug Celebrex as a pain reliever is a step toward a new treatment that could make it more accessible and affordable for people with chronic pain.
The company announced Tuesday it will begin using a combination of Celebrex with ibuprofen to reduce joint pain and inflammation for pain-free weeks.
Celebrex is a painkiller that is the first drug to treat arthritis, and it is used to treat other conditions such as osteoarthritis and rheumatoid arthritis.
Celebrex was launched in the United States as a non-steroidal anti-inflammatory drug (NSAID) at Pfizer Inc. in October 2007.
Celebrex is also known as celecoxib and is a combination medication of the two.
Pfizer Inc. is the largest generic pharmaceutical company in the world and is among the largest pharmaceutical companies. The company's U. S. headquarters is in New York City.
The company's marketing plan includes the use of celecoxib and ibuprofen as pain relief, but not all of them are considered pain-relieving.
Pfizer said it will use Celebrex to help reduce pain and reduce inflammation in patients with osteoarthritis, rheumatoid arthritis, and other chronic conditions.
Celebrex was launched in the United States in 2007 as a non-steroidal anti-inflammatory drug (NSAID) that is used to treat arthritis, but it will not treat arthritis.
The Celebrex label will cover a boxed warning about the risks associated with the use of Celebrex, including serious and potentially fatal reactions such as anaphylaxis.
The warning also includes a serious warning about the risk of severe allergic reactions, which are more common in patients taking NSAIDs such as ibuprofen and naproxen, and patients at increased risk of developing kidney problems, especially in those with a history of kidney failure.
Pfizer said it is working with a U. health care provider and will review the risks and benefits of its treatment and make recommendations for how to use it.
Pfizer has made the Celebrex launch more widely known in the United States than it did a few years ago when the drug was launched.
Pfizer will continue to market its arthritis drug to consumers, including its U. sales representatives, as well as to other U. drugmakers.
Pfizer will continue to use the Celebrex label as an aid to help reduce the pain and inflammation that people with arthritis often feel.
Celebrex is available under several brand names including Celebrex, Celebrex-R, Celebrex-S, Celebrex-T, and Celebrex-U.
The Celebrex label will cover a boxed warning about the risks associated with the use of Celebrex, including serious and potentially fatal reactions such as anaphylaxis, shock, and allergic reactions.
Celebrex has not been approved for pediatric use, and it is not currently approved for long-term use.
Pfizer said it is taking steps to address the increased demand for pain-relieving medicines that are increasingly being used to treat chronic pain.
Patients who use Celebrex or other pain relievers such as Advil should have a prescription from their doctor.
The company is also working with a U. government agency to develop a drug that can help people with arthritis get relief from arthritis pain.
Pfizer is also launching a new arthritis treatment called, which will cost more than $5 billion over five years.
The drug is available as a generic version of Pfizer's arthritis drug Celebrex.
The Celebrex label will cover a boxed warning about the risks of osteoarthritis and rheumatoid arthritis, as well as the risk of kidney problems and the need for dialysis for people with bone fractures.
The Celebrex label will also include a boxed warning that mentions the risk of heart attack, stroke, and kidney problems.
The Celebrex label also will include a boxed warning about serious and potentially fatal reactions to the drug, such as anaphylaxis, shock, and allergic reactions.
The Celebrex label will also cover a serious warning about anaphylaxis, which is a serious allergic reaction that occurs in less than 1 in 10 people who take Celebrex.
Stade de France Pharmacy